OTC Markets OTCPK - Delayed Quote USD

Innovative Holdings Alliance, Inc. (IHAI)

0.0807
-0.0268
(-24.93%)
As of 9:30:32 AM EDT. Market Open.
Loading Chart for IHAI
  • Previous Close 0.1075
  • Open 0.0807
  • Bid 0.0720 x --
  • Ask 0.1000 x --
  • Day's Range 0.0807 - 0.0807
  • 52 Week Range 0.0300 - 0.1495
  • Volume 9,000
  • Avg. Volume 55,239
  • Market Cap (intraday) 4.221M
  • Beta (5Y Monthly) 7.88
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Innovative Holdings Alliance, Inc., a medical technology holding company, offers personal care products in North America. The company offers arthritis cream product, a topical ointment that is used for site specific applications to provide temporary relief of pain and inflammation associated with arthritis and other musculoskeletal conditions. The company was formerly known as Innovative Health Sciences, Inc. and changed its name to Innovative Holdings Alliance, Inc. in May 2011. Innovative Holdings Alliance, Inc. was founded in 1996 and is based in Alpharetta, Georgia.

www.innovativeholdingsallianceinc.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IHAI

View More

Performance Overview: IHAI

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IHAI
30.16%
S&P 500 (^GSPC)
0.63%

1-Year Return

IHAI
10.33%
S&P 500 (^GSPC)
11.50%

3-Year Return

IHAI
88.30%
S&P 500 (^GSPC)
47.08%

5-Year Return

IHAI
16,040.00%
S&P 500 (^GSPC)
106.67%

Compare To: IHAI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IHAI

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    5.18M

  • Enterprise Value

    5.52M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    89k

  • Net Income Avi to Common (ttm)

    -416.71k

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.25k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IHAI

View More

Company Insights: IHAI

Research Reports: IHAI

View More

People Also Watch